Effect of maqui-berry extract in dry eye disease – A clinical and molecular analysis
Indian Journal of Ophthalmology · 2023
DOI: 10.4103/ijo.ijo_2909_22 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Indian Journal of Ophthalmology, 2023. Verfasst von Gairik Kundu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cornea and Refractive Surgery, Narayana Nethralaya, Bengaluru, Karnataka, India. Hauptthemen laut MEDLINE: Interleukin-10, Dry Eye Syndromes. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Purpose
This study aims to investigate the effects of maqui-berry extract (MBE) in improving signs and symptoms of dry eye disease (DED) along with ocular surface inflammation in patients with DED.
Methods
Twenty patients were randomly assigned to a MBE or a placebo group (PLC). DED parameters including Schirmer’s test 1 (ST1), tear film break-up time (TBUT), ocular surface disease index (OSDI), and corneal staining were assessed before treatment and 2 months post-treatment. Tear fluid samples before and after treatment from a subset of these patients were collected from the study subjects using sterile Schirmer’s strips, and the levels of interleukin (IL)-1β, IL-10, IL-6, IL-17A, tumor necrosis factor-α (TNFα), matrix metalloproteinase-9 (MMP9), soluble intercellular adhesion molecule-1 (sICAM1), and vascular endothelial growth factor-A (VEGF-A) were measured using a microfluidic cartridge-based multiplex ELISA.
Results
The MBE group demonstrated a significant ( p < 0.05) decrease in OSDI scores along with a significant increase in Schirmer’s test 1 compared to the PLC group. No significant change in TBUT and corneal staining was observed between the study groups. Levels of proinflammatory factors such as IL-1β, IL-6, IL-17A, TNFα, and MMP9 were observed to be significantly reduced, along with a significant increase in IL-10 levels following treatment in the MBE group compared with the PLC group.
Conclusion
Consumption of MBE resulted in the resolution of DED signs and symptoms, along with a reduction in ocular surface inflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cornea and Refractive Surgery, Narayana Nethralaya, Bengaluru, Karnataka, India.
- GROW Research Laboratory, Narayana Nethralaya Foundation, Bengaluru, Karnataka, India.
Zitieren
APA
Kundu, G., Shetty, R., D'Souza, S., Gorimanipalli, B., Koul, A., & Sethu, S. (2023). Effect of maqui-berry extract in dry eye disease – A clinical and molecular analysis. Indian Journal of Ophthalmology. https://doi.org/10.4103/ijo.ijo_2909_22
Vancouver
Kundu G, Shetty R, D'Souza S, Gorimanipalli B, Koul A, Sethu S. Effect of maqui-berry extract in dry eye disease – A clinical and molecular analysis. Indian Journal of Ophthalmology. 2023. doi:10.4103/ijo.ijo_2909_22
BibTeX
@article{Kundu2023,
author = {Kundu, Gairik and Shetty, Rohit and D'Souza, Sharon and Gorimanipalli, Bhavya and Koul, Ameeta and Sethu, Swaminathan},
title = {Effect of maqui-berry extract in dry eye disease – A clinical and molecular analysis},
journal = {Indian Journal of Ophthalmology},
year = {2023},
doi = {10.4103/ijo.ijo_2909_22}
}
EUVIMED